These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 36925448)

  • 1. A Narrative Review-Management of Malignant Pleural Effusion Related to Malignant Pleural Mesothelioma.
    Qureshi M; Thapa B; Muruganandan S
    Heart Lung Circ; 2023 May; 32(5):587-595. PubMed ID: 36925448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.
    Fontana V; Pistillo MP; Vigani A; Canessa PA; Berisso G; Giannoni U; Ferro P; Franceschini MC; Carosio R; Tonarelli M; Rossi C; Dessanti P; Roncella S
    Anticancer Res; 2019 Sep; 39(9):5219-5223. PubMed ID: 31519636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
    Yamada S; Tabata C; Tabata R; Fukuoka K; Nakano T
    Clin Chem Lab Med; 2011 Oct; 49(10):1721-6. PubMed ID: 21692685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
    Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
    BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
    Novello S; Pinto C; Torri V; Porcu L; Di Maio M; Tiseo M; Ceresoli G; Magnani C; Silvestri S; Veltri A; Papotti M; Rossi G; Ricardi U; Trodella L; Rea F; Facciolo F; Granieri A; Zagonel V; Scagliotti G
    Crit Rev Oncol Hematol; 2016 Aug; 104():9-20. PubMed ID: 27286698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical Pathological Diagnosis, and Treatment for Pleural Mesothelioma].
    Kishimoto T; Fujimoto N; Nishi H
    Gan To Kagaku Ryoho; 2016 May; 43(5):513-7. PubMed ID: 27210080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of malignant pleural mesothelioma.
    Rodríguez Panadero F
    Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology.
    Franceschini MC; Ferro P; Canessa PA; Battolla E; Dessanti P; Valentino A; Casolari L; Fontana V; Pezzi R; Fedeli F; Pistillo MP; Roncella S
    Anticancer Res; 2014 Dec; 34(12):7425-9. PubMed ID: 25503183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
    Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
    Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
    Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
    Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant pleural mesothelioma].
    Sritharan SS; Frandsen JL; Omland Ø; Bruun JM
    Ugeskr Laeger; 2018 Apr; 180(15):. PubMed ID: 29690982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
    Kinoshita Y; Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Hiroshima K; Oda Y; Nabeshima K
    Cancer Cytopathol; 2018 Jan; 126(1):54-63. PubMed ID: 29053210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.
    Lievense LA; Bezemer K; Cornelissen R; Kaijen-Lambers ME; Hegmans JP; Aerts JG
    Lung Cancer; 2017 May; 107():36-40. PubMed ID: 27168021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant Pleural Effusion in Malignant Pleural Mesothelioma: An Innocent Bystander?
    Muruganandan S; Duong V
    Chest; 2021 Nov; 160(5):1602-1603. PubMed ID: 34743845
    [No Abstract]   [Full Text] [Related]  

  • 15. Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue.
    Hida T; Matsumoto S; Hamasaki M; Kawahara K; Tsujimura T; Hiroshima K; Kamei T; Taguchi K; Iwasaki A; Oda Y; Honda H; Nabeshima K
    Cancer Sci; 2015 Nov; 106(11):1635-41. PubMed ID: 26291840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis.
    Gao R; Wang F; Wang Z; Wu Y; Xu L; Qin Y; Shi H; Tong Z
    Medicine (Baltimore); 2019 Apr; 98(14):e14979. PubMed ID: 30946324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of microRNAs in the diagnosis and treatment of malignant pleural mesothelioma--a short review.
    Sheff KW; Hoda MA; Dome B; Hegedus B; Klepetko W; Weiss GJ
    Microrna; 2012; 1(1):40-8. PubMed ID: 25048089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex Soluble Biomarker Analysis from Pleural Effusion.
    Javadi J; Dobra K; Hjerpe A
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32731396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center.
    Otoshi T; Kataoka Y; Ikegaki S; Saito E; Matsumoto H; Kaku S; Shimada M; Hirabayashi M
    PLoS One; 2017; 12(10):e0185850. PubMed ID: 28968445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
    Nakajima Y; Kuribayashi K; Ishigaki H; Tada A; Negi Y; Minami T; Takahashi R; Doi H; Kitajima K; Yokoi T; Kijima T
    Cancer Invest; 2020 Jul; 38(6):356-364. PubMed ID: 32468861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.